-
Bergenin Targets γδT17 Cells via PPARγ/PROX1 Axis in Psorias
2026-06-17
This study demonstrates that bergenin, a natural PPARγ agonist from Bergenia purpurascens, selectively suppresses pathogenic γδT17 cell activation in psoriasis via a novel PPARγ-mediated ubiquitination and degradation of PROX1. The findings establish a new immunometabolic mechanism for psoriasis therapy and identify precise cellular targets for plant-derived intervention.
-
Multiplexed ACE2 Libraries Uncover SARS-CoV-2 Variant Adapta
2026-06-16
Shukla et al. introduce a high-throughput barcoded assay to evaluate how SARS-CoV-2 spike variants interact with diverse ACE2 receptor sequences. Their findings demonstrate that spike mutations drive shifts in receptor compatibility, illuminating mechanisms of viral adaptation and potential cross-species transmission.
-
Pharmacokinetic Variability of CSBTA in MASH Mouse Models
2026-06-16
This study systematically elucidates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetic behavior and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a high-fat, high-cholesterol diet-induced mouse model. The findings highlight the critical influence of disease state and transporter/enzyme modulation on systemic and hepatic exposure of key alkaloids, providing a framework for optimizing dosing strategies in MASLD/MASH research.
-
Selective Nanomolar IRAP Inhibitors Inspired by Bestatin Sca
2026-06-15
This study presents a new class of α-hydroxy-β-amino acid derivatives based on bestatin, achieving highly selective, potent inhibition of insulin-regulated aminopeptidase (IRAP). The work elucidates structural determinants of selectivity and provides advanced chemical tools for aminopeptidase-related research and drug discovery.
-
Ro 3306: CDK1 Inhibitor for Precise Cell Cycle G2/M Arrest
2026-06-15
Ro 3306 is a selective CDK1 inhibitor that delivers robust, reversible G2/M phase arrest, enabling researchers to probe cell cycle regulation and DNA repair with exceptional clarity. Its proven potency and unique workflow advantages make it indispensable for synchronizing cancer cell populations and dissecting checkpoint dynamics.
-
Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:
2026-06-14
Wang et al. (2018) systematically dissected the entry mechanism of type III grass carp reovirus (GCRV104) using targeted inhibitor analysis, revealing that clathrin-mediated, pH-dependent endocytosis is essential for viral entry into host cells. Their findings clarify cellular requirements for GCRV infection and inform both antiviral strategy development and the design of mechanistic virology assays.
-
COX-2 Modulation in Snake Venom-Induced Muscle Ischemia
2026-06-13
This study uncovers how the cyclooxygenase-2 (COX-2) pathway regulates tissue ischemia and revascularization after Bothrops asper venom-induced skeletal muscle injury. Using temporally controlled selective inhibition with Lumiracoxib, the research delineates dual-phase roles of COX-2-derived prostaglandins in both protecting vasculature and facilitating later angiogenic remodeling.
-
Bafilomycin C1 (SKU C4729): Reliable V-ATPase Inhibition in
2026-06-12
This article addresses real-world laboratory challenges in autophagy, cytotoxicity, and phenotypic screening workflows, demonstrating how 'Bafilomycin C1' (SKU C4729) ensures reproducible, data-driven results. Drawing on peer-reviewed evidence and practical protocol optimization, we detail why Bafilomycin C1 from APExBIO is a trusted tool for biomedical researchers seeking robust V-ATPase inhibition.
-
0.4% Trypan Blue Solution: Assay Parameters and Best Practic
2026-06-12
0.4% Trypan Blue Solution enables researchers to rapidly assess cell viability and perform live/dead discrimination in cell culture workflows. It addresses the need for reliable, direct identification of non-viable cells, critical for accurate cell counting and viability measurement. This reagent is suitable solely for laboratory research, not for diagnostic or clinical use.
-
Clodronate Liposomes: Precision In Vivo Macrophage Depletion
2026-06-11
Clodronate Liposomes empower researchers with robust, tissue-specific macrophage depletion in vivo, enabling targeted immune cell modulation for complex disease models. This article highlights advanced workflows, troubleshooting, and the translational impact of liposome-encapsulated clodronate, as demonstrated in recent hepatic ischemia-reperfusion research.
-
PQQ Mitigates Age-Related Osteoarthritis via Nrf2–IGF1R Path
2026-06-11
This study reveals that long-term dietary pyrroloquinoline quinone (PQQ) protects against age-related osteoarthritis by activating Nrf2-mediated antioxidant responses and upregulating IGF1R in chondrocytes. These findings illuminate the molecular mechanisms of PQQ action and propose the Nrf2–IGF1R axis as a promising target for disease-modifying osteoarthritis interventions.
-
Cl-Amidine Trifluoroacetate Salt: Elevating PAD4 Inhibitor W
2026-06-10
Cl-Amidine (trifluoroacetate salt) empowers researchers with potent, selective PAD4 inhibition for precision studies in cancer, rheumatoid arthritis, and septic shock models. This guide provides protocol enhancements, experimental troubleshooting, and cross-study insights, maximizing reproducibility and biological insight with APExBIO’s trusted reagent.
-
Improving In Vitro Evaluation of Cancer Drug Responses: Insi
2026-06-10
Schwartz's dissertation introduces a rigorous approach to in vitro drug evaluation in cancer research, distinguishing between proliferative arrest and cell death using fractional and relative viability metrics. This nuanced framework clarifies how anti-cancer drugs like HDAC inhibitors trigger both growth inhibition and apoptosis, informing more precise experimental design and interpretation.
-
ICG001: Applied Wnt/β-Catenin Pathway Inhibition in Fibrosis
2026-06-09
ICG001 enables precise and selective dissection of Wnt/β-catenin-driven processes in fibrosis and cancer, distinguishing itself as a tool for both mechanistic studies and translational model validation. Its utility in EMT and organ-specific fibrosis workflows is informed by recent breakthroughs in understanding β-catenin’s role in disease progression.
-
CB-5083 (SKU B6032): Practical Solutions for p97 Inhibition
2026-06-09
This article provides an evidence-driven, scenario-based guide to using CB-5083 (SKU B6032) as a selective p97 inhibitor in assays targeting protein homeostasis, cancer apoptosis, and tumor growth models. Biomedical researchers and lab technicians will find actionable guidance on protocol optimization, data interpretation, and product selection, with all recommendations grounded in quantitative findings and real-world best practices.